Alcon Laboratories (U.K) Limited

Pentagon Park, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 7UD
Telephone: +44 (0)1442 341 234
Fax: +44 (0)1442 341 200

Summary of Product Characteristics last updated on the eMC: 07/12/2011
SPC Emadine 0.05% w/v, Eye Drops, Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
Date of revision of text on the SPC:   30-Nov-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Removal of 'multi-dose container'.
Updated on 11/03/2009 and displayed until 07/12/2011
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   02-Feb-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.2 - Whole section amended

Section 4.4 - Whole section amended

Section 4.8 - Whole section amended
Updated on 17/01/2002 and displayed until 11/03/2009
Reasons for adding or updating:
  • Removal of Black Triangle
Updated on 13/08/2001 and displayed until 17/01/2002
Reasons for adding or updating:
  • Addition of Black Triangle
Updated on 10/07/2001 and displayed until 13/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 22/06/2001 and displayed until 10/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 09/11/2000 and displayed until 22/06/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   emedastine difumarate